Literature DB >> 19817804

Interobserver and intraobserver reproducibility in focal cortical dysplasia (malformations of cortical development).

Wendy A Chamberlain1, Mark L Cohen, Kymberly A Gyure, Bette K Kleinschmidt-DeMasters, Arie Perry, Suzanne Z Powell, Jiang Qian, Susan M Staugaitis, Richard A Prayson.   

Abstract

PURPOSE: Malformations of cortical development (MCD) (cortical dysplasias) are well-recognized causes of intractable epilepsy. Although a histologic classification system for MCD has been proposed by Palmini et al. (Neurology; 2004; 62:S2), studies to date have not assessed reproducibility. The purpose of this study was to analyze inter- and intraobserver agreement among eight experienced neuropathologists (NPs) with respect to this classification system.
METHODS: Sections from 26 epilepsy resections were selected to represent the range of pathologies described by Palmini et al. Recuts of single sections from each case were sent to the NPs to classify. The slides were resent at a later date for reclassification. Kappa analysis for both inter- and intraobserver concordance was performed.
RESULTS: Interobserver agreement was moderate (kappa = 0.4968). There was > or =62.5% (5 of 8 NPs) agreement for 19 of 26 cases. The greatest concordance was present when making focal cortical dysplasia (FCD) types IIA/B classifications (12 of the 14 cases with > or =75% consensus). Mild MCD (types I/II) and FCD types IA/B classifications were the least reproducible, and used most frequently in cases without consensus. Intraobserver concordance was moderate to very good (range kappa = 0.4654-0.8504). The category with the fewest classification changes made on reevaluation was FCD type IIB (4.2%), whereas that with the most changes was mild MCD (types I/II) (52.9%). DISCUSSION: Interobserver concordance using this approach was moderate. The classification categories with the greatest concordance were FCD type IIA/B, and the least, mild MCD and FCD types IA/B. In addition, difficulty in differentiating Mild MCD/FCD type I lesions from normal and/or gliotic tissue was noted.

Entities:  

Mesh:

Year:  2009        PMID: 19817804     DOI: 10.1111/j.1528-1167.2009.02344.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  17 in total

1.  Optimizing MR imaging detection of type 2 focal cortical dysplasia: best criteria for clinical practice.

Authors:  C Mellerio; M-A Labeyrie; F Chassoux; C Daumas-Duport; E Landre; B Turak; F-X Roux; J-F Meder; B Devaux; C Oppenheim
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-03       Impact factor: 3.825

2.  Epilepsy: the new order-classifying focal cortical dysplasias.

Authors:  Sanjay Sisodiya
Journal:  Nat Rev Neurol       Date:  2011-03       Impact factor: 42.937

Review 3.  Epilepsy associated tumors: Review article.

Authors:  Marco Giulioni; Gianluca Marucci; Matteo Martinoni; Anna Federica Marliani; Francesco Toni; Fiorina Bartiromo; Lilia Volpi; Patrizia Riguzzi; Francesca Bisulli; Ilaria Naldi; Roberto Michelucci; Agostino Baruzzi; Paolo Tinuper; Guido Rubboli
Journal:  World J Clin Cases       Date:  2014-11-16       Impact factor: 1.337

Review 4.  Epilepsy related to developmental tumors and malformations of cortical development.

Authors:  Eleonora Aronica; Peter B Crino
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 5.  Classification and pathological characteristics of the cortical dysplasias.

Authors:  Richard A Prayson
Journal:  Childs Nerv Syst       Date:  2014-10-09       Impact factor: 1.475

Review 6.  Outcome after epilepsy surgery for cortical dysplasia in children.

Authors:  Ahsan N V Moosa; Ajay Gupta
Journal:  Childs Nerv Syst       Date:  2014-11       Impact factor: 1.475

7.  The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission.

Authors:  Ingmar Blümcke; Maria Thom; Eleonora Aronica; Dawna D Armstrong; Harry V Vinters; Andre Palmini; Thomas S Jacques; Giuliano Avanzini; A James Barkovich; Giorgio Battaglia; Albert Becker; Carlos Cepeda; Fernando Cendes; Nadia Colombo; Peter Crino; J Helen Cross; Olivier Delalande; François Dubeau; John Duncan; Renzo Guerrini; Philippe Kahane; Gary Mathern; Imad Najm; Ciğdem Ozkara; Charles Raybaud; Alfonso Represa; Steven N Roper; Noriko Salamon; Andreas Schulze-Bonhage; Laura Tassi; Annamaria Vezzani; Roberto Spreafico
Journal:  Epilepsia       Date:  2010-11-10       Impact factor: 5.864

8.  Cytochrome c oxidase deficit is associated with the seizure onset zone in young patients with focal cortical dysplasia Type II.

Authors:  Lili Miles; Hansel M Greiner; Francesco T Mangano; Paul S Horn; James L Leach; Michael V Miles
Journal:  Metab Brain Dis       Date:  2015-05-10       Impact factor: 3.584

9.  The application of cortical layer markers in the evaluation of cortical dysplasias in epilepsy.

Authors:  George Hadjivassiliou; Lillian Martinian; Waney Squier; Ingmar Blumcke; Eleonora Aronica; Sanjay M Sisodiya; Maria Thom
Journal:  Acta Neuropathol       Date:  2010-04-22       Impact factor: 17.088

10.  Automated detection of focal cortical dysplasia type II with surface-based magnetic resonance imaging postprocessing and machine learning.

Authors:  Bo Jin; Balu Krishnan; Sophie Adler; Konrad Wagstyl; Wenhan Hu; Stephen Jones; Imad Najm; Andreas Alexopoulos; Kai Zhang; Jianguo Zhang; Meiping Ding; Shuang Wang; Zhong Irene Wang
Journal:  Epilepsia       Date:  2018-04-10       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.